
PRGO
USDPerrigo Company plc Ordinary Shares
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$27.670
High
$27.290
Low
$26.965
Volume
0.87M
Company Fundamentals
Market Cap
3.7B
Industry
Drug Manufacturers - Specialty & Generic
Country
Ireland
Trading Stats
Avg Volume
1.45M
Exchange
NYQ
Currency
USD
52-Week Range
AI Analysis Report
Last updated: May 25, 2025PRGO: Perrigo Company plc Ordinary Shares – Unpacking Recent Trends and Future Signals
Stock Symbol: PRGO Generate Date: 2025-05-25 12:25:03
Let's break down what's been happening with Perrigo and what the numbers might be telling us.
Recent News Buzz
The news flow for Perrigo has been a bit of a mixed bag lately. On one hand, the company announced its CEO, Patrick Lockwood-Taylor, will be attending the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference. This kind of event participation often signals a company's desire to engage with investors and highlight future growth prospects. It's generally seen as a positive, showing management is out there, talking up the business.
However, earlier in May, Perrigo released its First Quarter 2025 financial results. The headline there was a 3.5% decline in net sales, hitting $1.04 billion. A big chunk of that drop, 3.2% to be exact, came from businesses they've divested. So, while the overall sales number looks down, it's important to remember some of that is due to strategic changes, not necessarily a core business slowdown. Still, a sales decline isn't usually what investors want to see, even with explanations.
Price Check
Looking at the stock's journey over the last few months, it's been quite a ride. Back in late February, PRGO was hovering around the $25 mark. Then, we saw a pretty sharp jump, with the stock hitting nearly $29 by early March. After that, it settled into a bit of a range, mostly between $27 and $28 through March.
Things got a little bumpy in early April, with a noticeable dip, even touching below $24 briefly. Since then, the stock has shown some resilience. We've seen it climb back up, especially around the time of the earnings report on May 7th, where it jumped from around $25 to over $26. The most recent trading day, May 23rd, saw the stock close at $26.56.
Comparing this to the AI's predictions, it's interesting. Today's prediction is flat (0.00%), but then it projects a modest increase: 1.12% for the next day and 1.72% for the day after that. This suggests the AI sees some gentle upward momentum in the very near term.
Outlook & Ideas
Putting it all together, the situation for Perrigo seems to lean towards a "hold" with a potential for short-term accumulation for those looking to enter.
Here's why: The recent sales decline, while explained by divestitures, still creates a cautious sentiment. However, the company's active engagement with investors (like the upcoming conference) and the stock's recent rebound from its April lows suggest underlying interest. The AI's short-term upward prediction also adds a touch of optimism.
-
Potential Entry Consideration: If you're thinking about getting in, the current price around $26.56 looks like a possible area. The AI model from AIPredictStock.com points to $26.47 and $26.59 as potential entry points. This aligns with the idea that the stock is near a support level, which could offer a good spot to consider buying. The technical analysis also flags the stock as "oversold" (RSI at 29.0), which sometimes means it's due for a bounce.
-
Potential Exit/Stop-Loss Consideration: For managing risk, a stop-loss around $23.76 could be considered. This level is below some recent lows and would help limit potential losses if the stock takes an unexpected turn downwards. On the upside, if the stock does move higher, a take-profit target around $26.92 is suggested by the AI model. Beyond that, analysts have an average price target of $34.60, which offers a significant long-term upside if the company can turn its fundamentals around.
Company Context
Remember, Perrigo is a major player in "Consumer Self-Care Products." This means they sell things like over-the-counter medicines, infant formulas, and skincare items. These are often considered defensive products, meaning people tend to buy them regardless of the economic climate. However, the recent negative revenue growth and low Return on Equity are points to watch. The company also carries a fair bit of debt, which is something to keep in mind. On the flip side, its P/E ratio is quite a bit lower than the industry average, which could make it look attractive to value investors.
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in stocks involves risks, and you could lose money. Always conduct your own thorough research or consult with a qualified financial professional before making any investment decisions.
Related News
Perrigo Announces Global Operations and Supply Chain Leadership Transition
Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced the appointment of Matt Winterman as...
Perrigo to Attend the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference
Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor...
AI PredictionBeta
AI Recommendation
Updated at: Jun 12, 2025, 01:43 PM
68.3% Confidence
Risk & Trading
Entry Point
$27.29
Take Profit
$27.92
Stop Loss
$24.63
Key Factors
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.